Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma.

@article{Neagu2010ImmunerelatedBF,
  title={Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma.},
  author={Monica Neagu and Carolina Constantin and Cristiana Tanase},
  journal={Expert review of molecular diagnostics},
  year={2010},
  volume={10 7},
  pages={
          897-919
        }
}
Skin melanoma, a life-threatening disease, has a recently reported worldwide increase in incidence, despite primary prevention. Skin melanoma statistics emphasize the need for finding markers related to the immune response of the host. The mechanisms that are able to over-power the local immune surveillance comprise molecules that can be valuable markers for diagnosis and prognosis. This article summarizes the immune markers that can monitor the disease stage and evaluate the efficacy of… CONTINUE READING
BETA

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 128 REFERENCES

Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p 53 , CDKN 2 A and NRas genes

  • C Lalou, N Scamuffa, S Mourah
  • PLoS ONE
  • 2010

Similar Papers

Loading similar papers…